PRODRUGS AND USES THEREOF

Patent Number: JP-2023106355-A

Publication Year: 2023

Application Year: 2023

Priority Year: 2022

Jurisdictions: JP

Status: Granted

Inventors:

KNERR PATRICK JAMES KNERR PATRICK JAMES KNERR PATRICK JAMES KNERR PATRICK JAMES KNERR PATRICK JAMES KNERR PATRICK JAMES KNERR PATRICK JAMES PATRICK JAMES KNERR PATRICK JAMES KNERR PATRICK JAMES KNERR パトリック・ジェイムズ・ナー BRIAN PATRICK FINAN BRIAN PATRICK FINAN BRIAN PATRICK FINAN FINAN BRIAN PATRICK FINAN BRIAN PATRICK FINAN BRIAN PATRICK FINAN BRIAN PATRICK FINAN BRIAN PATRICK FINAN BRIAN PATRICK FINAN BRIAN PATRICK パトリック・ジェイムズ・ナー

Applicants:

  1. Novo Nordisk (Denmark)
    2. [NORA names: Novo Nordisk; Private Research; Denmark; Europe, EU; Nordic; OECD]

Abstract

Prodrug compounds of GLP-1/GIP receptor co-agonists are provided wherein the GLP-1/GIP receptor co-agonists have been modified by the linkage of a dipeptide to the GLP-1/GIP receptor co-agonist through an amide bond. The prodrugs disclosed herein have extended half-lives and are converted to the active GLP-1/GIP receptor co-agonist at physiological conditions through a non-enzymatic reaction driven by chemical instability.

Patent Family Records (11)

PRODRUGS AND USES THEREOF  

Novo Nordisk (Denmark), Novo Nordisk AS KNERR PATRICK JAMES, FINAN BRIAN PATRICK

2024, US-20240083965-A1

Prodrugs and their use  

Novo Nordisk (Denmark), Novo Nordisk AS パトリック・ジェイムズ・ナー, ブライアン・パトリック・ファイナン

2024, JP-7434616-B2

PRODRUGS AND USES THEREOF  

Novo Nordisk (Denmark), Novo Nordisk AS PATRICK JAMES KNERR, BRIAN PATRICK FINAN

2024, JP-2024015148-A

PRODRUGS AND THEIR USES  

NOVO NORDISK AS, Novo Nordisk (Denmark) KNERR PATRICK JAMES, FINAN BRIAN PATRICK

2024, AR-128315-A1

GLP-1/GIP RECEPTOR CO-AGONIST PRODRUGS AND USES THEREOF  

NOVO NORDISK AS, Novo Nordisk (Denmark) KNERR PATRICK JAMES, FINAN BRIAN PATRICK

2023, WO-2023139187-A1

PRODRUGS AND USES THEREOF  

Novo Nordisk (Denmark), Novo Nordisk AS KNERR PATRICK JAMES, FINAN BRIAN PATRICK

2023, US-20230227521-A1

Prodrugs and uses thereof  

Novo Nordisk (Denmark), Novo Nordisk AS KNERR PATRICK JAMES, FINAN BRIAN PATRICK

2023, US-11840560-B2

PRODRUGS AND USES THEREOF  

NOVO NORDISK AS, Novo Nordisk (Denmark) KNERR PATRICK JAMES, FINAN BRIAN PATRICK

2023, TW-202330584-A

PRODRUGS AND USES THEREOF  

NOVO NORDISK A, Novo Nordisk (Denmark) PATRICK JAMES KNERR, BRIAN PATRICK FINAN

2023, KR-20230159805-A

PRODRUGS AND USES THEREOF  

NOVO NORDISK A, Novo Nordisk (Denmark) KNERR PATRICK JAMES, FINAN BRIAN PATRICK

2023, KR-20230112568-A

PRODRUGS AND USES THEREOF

Novo Nordisk (Denmark), Novo Nordisk AS PATRICK JAMES KNERR, BRIAN PATRICK FINAN

2023, JP-2023106355-A

Data Provider: Digital Science

LINKS
+

External Systems

SUBJECTS
+

PATENT CATEGORIES
+

METRICS
+

Citation Metrics

Times Cited in Patents: 0external link

References to Patents: [No Data Available]

References to Publications: 0external link